Cytodyn Inc. (CYDY) 10-K Annual Report September 2023

Cover Page - USD ($)	12 Months Ended
Cover Page - USD ($)	May 31, 2023	Aug. 31, 2023	Nov. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	May 31, 2023
Entity File Number	000-49908
Entity Registrant Name	CytoDyn Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-1887078
Entity Address, Address Line One	1111 Main Street, Suite 660
Entity Address, City or Town	Vancouver
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98660
City Area Code	360
Local Phone Number	980-8524
Title of 12(g) Security	Common Stock, par value $0.001 per share
No Trading Symbol Flag	true
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
ICFR Auditor Attestation Flag	false
Entity Common Stock, Shares Outstanding		930,960,097
Entity Public Float			$ 295,738,201
Auditor Name	Macias Gini & O’Connell LLP
Auditor Firm ID	324
Auditor Location	San Jose, California
Current Fiscal Year End Date	--05-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Central Index Key	0001175680
Amendment Flag	false

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1175680/000155837023015718/cydy-20230531x10k.htm

View differences made from one year to another to evaluate Cytodyn Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Cytodyn Inc..

Continue

Assess how Cytodyn Inc.'s management team is paid from their Annual Proxy

Cytodyn Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Material Contracts, Statements, Certifications & more

Cytodyn Inc. provided additional information to their SEC Filing as exhibits

Exhibit 4.1: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 4.19: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 4.20: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 21: Subsidaries Of The Registrant

Exhibit 23: Consents Of Experts And Counsel

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 32: Section 1350 Certification

Ticker: CYDY
CIK: 1175680
Form Type: 10-K Annual Report
Accession Number: 0001558370-23-015718
Submitted to the SEC: Wed Sep 13 2023 5:34:05 PM EST
Accepted by the SEC: Thu Sep 14 2023
Period: Wednesday, May 31, 2023
Industry: Pharmaceutical Preparations